These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21422741)

  • 1. Exploring the mechanisms of renoprotection against progressive glomerulosclerosis.
    Oite T
    Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(3):81-90. PubMed ID: 21422741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disturbances of glomerular hemodynamics: a risk factor determing progression of glomerular diseases?
    Oite T; Yao J
    J Nephrol; 2009; 22(2):196-202. PubMed ID: 19384836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local delivery of a direct renin inhibitor into the kidney ameliorates progression of experimental glomerulonephritis.
    Sato A; Piao H; Nozawa Y; Morioka T; Kawachi H; Oite T
    Clin Exp Nephrol; 2012 Aug; 16(4):539-48. PubMed ID: 22327564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local delivery of angiotensin receptor blocker into the kidney ameliorates progression of experimental glomerulonephritis.
    Mahmood J; Khan F; Okada S; Kumagai N; Morioka T; Oite T
    Kidney Int; 2006 Nov; 70(9):1591-8. PubMed ID: 16985512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of vascular regeneration precedes progressive glomerulosclerosis in anti-Thy 1 glomerulonephritis.
    Wada Y; Morioka T; Oyanagi-Tanaka Y; Yao J; Suzuki Y; Gejyo F; Arakawa M; Oite T
    Kidney Int; 2002 Feb; 61(2):432-43. PubMed ID: 11849383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirt1 activation prevents anti-Thy 1.1 mesangial proliferative glomerulonephritis in the rat through the Nrf2/ARE pathway.
    Huang K; Li R; Wei W
    Eur J Pharmacol; 2018 Aug; 832():138-144. PubMed ID: 29782856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular expression of neuronal activity-regulated pentraxin precedes the development of anti-Thy-1-induced progressive glomerulosclerosis.
    Aben JA; Ijpelaar DH; Baelde H; Worley P; Noble N; Bruijn JA; de Heer E
    Kidney Int; 2006 Oct; 70(7):1279-86. PubMed ID: 16900090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of renal administration of a selective cyclooxygenase-2 inhibitor or stable prostaglandin I2 analog on the progression of sclerotic glomerulonephritis in rats.
    Nozawa Y; Sato A; Piao H; Morioka T; Narita I; Oite T
    Clin Exp Nephrol; 2012 Apr; 16(2):221-30. PubMed ID: 22147282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of selective inhibition or activation of PGE2 EP1 receptor on glomerulosclerosis.
    Chen X; Yin J; Xu Y; Qiu Z; Liu J; Chen X
    Mol Med Rep; 2020 Oct; 22(4):2887-2895. PubMed ID: 32700746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular mesangial cell recruitment and function require the co-receptor neuropilin-1.
    Bartlett CS; Scott RP; Carota IA; Wnuk ML; Kanwar YS; Miner JH; Quaggin SE
    Am J Physiol Renal Physiol; 2017 Dec; 313(6):F1232-F1242. PubMed ID: 28835419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal functional reserve in experimental chronic glomerulonephritis.
    De Nicola L; Peterson OW; Obagi S; Kaiser JA; Wilson CB; Gabbai FB
    Nephrol Dial Transplant; 1994; 9(10):1383-9. PubMed ID: 7816249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonic hedgehog connects podocyte injury to mesangial activation and glomerulosclerosis.
    Zhou D; Fu H; Han Y; Zhang L; Liu S; Lin L; Stolz DB; Liu Y
    JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31647783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
    Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
    Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis.
    Minutolo R; Balletta MM; Catapano F; Chiodini P; Tirino G; Zamboli P; Fuiano G; Russo D; Marotta P; Iodice C; Conte G; De Nicola L
    Kidney Int; 2006 Sep; 70(6):1170-6. PubMed ID: 16883322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis.
    Guo L; Luo S; Du Z; Zhou M; Li P; Fu Y; Sun X; Huang Y; Zhang Z
    Nat Commun; 2017 Oct; 8(1):878. PubMed ID: 29026082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of STAT3/Smad1 is a key signaling pathway for progression to glomerulosclerosis in experimental glomerulonephritis.
    Takahashi T; Abe H; Arai H; Matsubara T; Nagai K; Matsuura M; Iehara N; Yokode M; Nishikawa S; Kita T; Doi T
    J Biol Chem; 2005 Feb; 280(8):7100-6. PubMed ID: 15591053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects and mechanisms of angiotensin II receptor blockade with telmisartan in a normotensive model of mesangioproliferative nephritis.
    Villa L; Boor P; Konieczny A; Kunter U; van Roeyen CR; Denecke B; Gan L; Kupper MB; Hoffmann K; Eitner F; Ostendorf T; Floege J
    Nephrol Dial Transplant; 2011 Oct; 26(10):3131-43. PubMed ID: 21414972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic predisposition for glomerulonephritis-induced glomerulosclerosis in rats is linked to chromosome 1.
    Ijpelaar DH; Schulz A; Aben J; van der Wal A; Bruijn JA; Kreutz R; de Heer E
    Physiol Genomics; 2008 Oct; 35(2):173-81. PubMed ID: 18682577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lipids on the pathogenesis of progressive renal failure: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the prevention of glomerulosclerosis.
    Guijarro C; Keane WF
    Miner Electrolyte Metab; 1996; 22(1-3):147-52. PubMed ID: 8676808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.